•
Sep 30, 2022

Wyndham Q3 2022 Earnings Report

Wyndham's Q3 2022 results were reported with raised full-year outlook and increased share repurchase authorization.

Key Takeaways

Wyndham Hotels & Resorts reported strong Q3 2022 results, with global RevPAR growing by 12% and system-wide rooms increasing by 4%. The company raised its full-year 2022 outlook and increased its share repurchase authorization by $400 million.

Global RevPAR increased by 12% compared to Q3 2021 in constant currency.

System-wide rooms grew by 4% year-over-year, with 1% growth in the U.S. and 9% internationally.

The development pipeline expanded by 10% year-over-year to 212,000 rooms.

Hotel Franchising segment revenues grew by 9% year-over-year.

Total Revenue
$407M
Previous year: $463M
-12.1%
EPS
$1.21
Previous year: $1.16
+4.3%
$49.2
Previous year: $45.8
+7.4%
836K
Previous year: 802.6K
+4.2%
U.S. RevPAR
$59.2
Previous year: $57.7
+2.5%
Gross Profit
$228M
Previous year: $247M
-7.7%
Cash and Equivalents
$286M
Previous year: $193M
+48.2%
Free Cash Flow
$97M
Previous year: $141M
-31.2%
Total Assets
$4.21B
Previous year: $4.31B
-2.3%

Wyndham

Wyndham

Wyndham Revenue by Segment

Forward Guidance

The Company is updating its outlook as follows: Year-over-year rooms growth~4%, Year-over-year global RevPAR growth 14 - 16%, Fee-related and other revenues $1.33 - $1.34 billion, Adjusted EBITDA $636 - $644 million, Adjusted net income $349 - $354 million, Adjusted diluted EPS $3.84 - $3.89, Free cash flow conversion rate ~55%

Positive Outlook

  • Year-over-year rooms growth ~4%
  • Year-over-year global RevPAR growth 14 - 16%
  • Fee-related and other revenues $1.33 - $1.34 billion
  • Adjusted EBITDA $636 - $644 million
  • Adjusted net income $349 - $354 million

Challenges Ahead

  • Free cash flow conversion rate ~55%
  • Unpredictable amount of adjustments
  • Potential adjustments may arise in the future during the forward-looking period
  • Dependent on future events that may not be reliably predicted
  • Excluded items could be material, individually or in the aggregate, to the reported results